Quinn JE - Search Results

1

PARP inhibition induces BAX/BAK-independent synthetic lethality of BRCA1-deficient non-small cell lung cancer.

Paul I, Savage KI, Blayney JK, Lamers E, Gately K, Kerr K, Sheaff M, Arthur K, Richard DJ, Hamilton PW, James JA, O'Byrne KJ, Harkin DP, Quinn JE, Fennell DA. Paul I, et al. Among authors: quinn je. J Pathol. 2011 Aug;224(4):564-74. doi: 10.1002/path.2925. Epub 2011 Jun 27. J Pathol. 2011. PMID: 21706479

2

BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma.

Busacca S, Sheaff M, Arthur K, Gray SG, O'Byrne KJ, Richard DJ, Soltermann A, Opitz I, Pass H, Harkin DP, Quinn JE, Fennell DA. Busacca S, et al. Among authors: quinn je. J Pathol. 2012 Jun;227(2):200-8. doi: 10.1002/path.3979. Epub 2012 Mar 19. J Pathol. 2012. PMID: 22190288

3

BRCA1: mechanisms of inactivation and implications for management of patients.

Kennedy RD, Quinn JE, Johnston PG, Harkin DP. Kennedy RD, et al. Among authors: quinn je. Lancet. 2002 Sep 28;360(9338):1007-14. doi: 10.1016/S0140-6736(02)11087-7. Lancet. 2002. PMID: 12383682 Review.

4

BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis.

Quinn JE, Kennedy RD, Mullan PB, Gilmore PM, Carty M, Johnston PG, Harkin DP. Quinn JE, et al. Cancer Res. 2003 Oct 1;63(19):6221-8. Cancer Res. 2003. PMID: 14559807

5

The role of BRCA1 in the cellular response to chemotherapy.

Kennedy RD, Quinn JE, Mullan PB, Johnston PG, Harkin DP. Kennedy RD, et al. Among authors: quinn je. J Natl Cancer Inst. 2004 Nov 17;96(22):1659-68. doi: 10.1093/jnci/djh312. J Natl Cancer Inst. 2004. PMID: 15547178 Review.

6

BRCA1, a potential predictive biomarker in the treatment of breast cancer.

James CR, Quinn JE, Mullan PB, Johnston PG, Harkin DP. James CR, et al. Among authors: quinn je. Oncologist. 2007 Feb;12(2):142-50. doi: 10.1634/theoncologist.12-2-142. Oncologist. 2007. PMID: 17296808 Free article. Review.

7

BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy.

Quinn JE, James CR, Stewart GE, Mulligan JM, White P, Chang GK, Mullan PB, Johnston PG, Wilson RH, Harkin DP. Quinn JE, et al. Clin Cancer Res. 2007 Dec 15;13(24):7413-20. doi: 10.1158/1078-0432.CCR-07-1083. Clin Cancer Res. 2007. PMID: 18094425

8

BRCA1 and implications for response to chemotherapy in ovarian cancer.

Quinn JE, Carser JE, James CR, Kennedy RD, Harkin DP. Quinn JE, et al. Gynecol Oncol. 2009 Apr;113(1):134-42. doi: 10.1016/j.ygyno.2008.12.015. Epub 2009 Jan 24. Gynecol Oncol. 2009. PMID: 19168207 Review.

9

BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer.

Carser JE, Quinn JE, Michie CO, O'Brien EJ, McCluggage WG, Maxwell P, Lamers E, Lioe TF, Williams AR, Kennedy RD, Gourley C, Harkin DP. Carser JE, et al. Among authors: quinn je. Gynecol Oncol. 2011 Dec;123(3):492-8. doi: 10.1016/j.ygyno.2011.08.017. Epub 2011 Sep 13. Gynecol Oncol. 2011. PMID: 21920589

10

BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers.

Buckley NE, Nic An tSaoir CB, Blayney JK, Oram LC, Crawford NT, D'Costa ZC, Quinn JE, Kennedy RD, Harkin DP, Mullan PB. Buckley NE, et al. Among authors: quinn je. Nucleic Acids Res. 2013 Oct;41(18):8601-14. doi: 10.1093/nar/gkt626. Epub 2013 Jul 17. Nucleic Acids Res. 2013. PMID: 23863842 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page